English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Gastric mixed adenoneuroendocrine carcinomas (G-MANEC) are rare malignancies with about 40 cases reported to date in English literature. Clinically, G-MANEC is characterized by aggressive behavior with rapid progression including a high incidence of regional and distant metastasis, leading to tumor-related death without any chance of surgical resection. Moreover, there is no uniform standard adjuvant chemotherapy for G-MANEC. Here, we report a case of G-MANEC with extensive liver metastases that gained survival benefits from neoadjuvant chemotherapy. A brief discussion of the biological behavior and treatment of G-MANEC is presented.

Gastric Mixed Adenoneuroendocrine Carcinoma with Extensive Liver Metastases Treated with Neoadjuvant Chemotherapy and Surgery